2 terminated, 2 unknown, 1 active not recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 2, Unknown 2, Active not recruiting 1 |
Follow Concurrent chemoradiation: new trials by email Literature Review of Concurrent chemoradiation trials Research Report on Concurrent chemoradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer Oxaliplatin, Tegafur-Gimeracil-Oteracil, Sintilimab - Stomach Neoplasms, Esophagogastric Junction Disorder | Phase 2 | Terminated | Fudan University | 6 | 2021-09-28 | 2025-06-18 |
| Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma Anlotinib hydrochloride, induction chemotherapy, concurrent chemoradiation - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Zhejiang Cancer Hospital | 37 | 2021-01-01 | 2022-02-10 |
| NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer Pembrolizumab - NPC | Phase 2 | Active not recruiting | Chinese University of Hong Kong | 43 | 2019-05-03 | 2025-12-24 |
| Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma Radiotherapy alone, Concurrent chemoradiation - Extranodal NK/T-cell Lymphoma, Nasal Type | Phase 2 | Terminated | Fudan University | 4 | 2012-06-01 | 2013-03-05 |
| Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients concurrent chemoradiation - Gastric Cancer | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 40 | 2011-10-01 | 2015-02-05 |
Stomach Neoplasms (2) · Adenocarcinoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Nasopharyngeal Carcinoma (1)
Fudan University (2) · Chinese Academy of Medical Sciences (1) · Chinese University of Hong Kong (1) · Zhejiang Cancer Hospital (1)
China (4) · Hong Kong (1) · Singapore (1)
Ye Guo, MD (1)